Gene · 859
Papers2,790
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 2,790
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Hybrid computational modeling highlights reverse warburg effect in breast cancer-associated fibroblasts. | Comput Struct Biotechnol J | 2023 | 37705596 | PubTator, text mining | PubMed |
| Combined sequence and copy number analysis improves diagnosis of limb girdle and other myopathies. | Ann Clin Transl Neurol | 2023 | 37688281 | PubTator, text mining | PubMed |
| Micro-Executor of Natural Products in Metabolic Diseases. | Molecules | 2023 | 37687031 | PubTator, text mining | PubMed |
| Whole-Genome Sequencing Identified New Structural Variations in the DMD Gene That Cause Duchenne Muscular Dystrophy in Two Girls. | Int J Mol Sci | 2023 | 37686372 | PubTator, text mining | PubMed |
| Dual Adeno-Associated Virus 9 with Codon-Optimized DYSF Gene Promotes In Vivo Muscle Regeneration and May Decrease Inflammatory Response in Limb Girdle Muscular Dystrophy Type R2. | Int J Mol Sci | 2023 | 37686363 | PubTator, text mining | PubMed |
| Caveolin-3 loss linked with the P104L LGMD-1C mutation modulates skeletal muscle mTORC1 signalling and cholesterol homeostasis. | J Cachexia Sarcopenia Muscle | 2023 | 37671684 | PubTator, text mining | PubMed |
| Genetic Defect in Submucosal Gland-Associated Caveolin-3: A New Paradigm in Esophageal Adenocarcinoma Risk. | Gastroenterology | 2023 | 37659676 | PubTator, text mining | PubMed |
| Inactivation influences the extent of inhibition of voltage-gated Ca+2 channels by Gem-implications for channelopathies. | Front Physiol | 2023 | 37654674 | PubTator, text mining | PubMed |
| Cell-in-cell: a potential biomarker of prognosis and a novel mechanism of drug resistance in cancer. | Front Oncol | 2023 | 37637068 | PubTator, text mining | PubMed |
| Current Classification of Canine Muscular Dystrophies and Identification of New Variants. | Genes (Basel) | 2023 | 37628610 | PubTator, text mining | PubMed |
| The Activation of the LIMK/Cofilin Signaling Pathway via Extracellular Matrix-Integrin Interactions Is Critical for the Generation of Mature and Vascularized Cardiac Organoids. | Cells | 2023 | 37626839 | PubTator, text mining | PubMed |
| Genome-Wide Analysis of Kidney Renal Cell Carcinoma: Exploring Differentially Expressed Genes for Diagnostic and Therapeutic Targets. | OMICS | 2023 | 37624678 | PubTator, text mining | PubMed |
| Arrhythmic Effects Evaluated on Caenorhabditis elegans: The Case of Polypyrrole Nanoparticles. | ACS Nano | 2023 | 37624669 | PubTator, text mining | PubMed |
| Predicting the molecular mechanism-driven progression of breast cancer through comprehensive network pharmacology and molecular docking approach. | Sci Rep | 2023 | 37607964 | PubTator, text mining | PubMed |
| Research trends and hotspots on the links between caveolin and cancer: bibliometric and visual analysis from 2003 to 2022. | Front Pharmacol | 2023 | 37576808 | PubTator, text mining | PubMed |
| Transcriptomic analysis of paired healthy human skeletal muscles to identify modulators of disease severity in DMD. | Front Genet | 2023 | 37576554 | PubTator, text mining | PubMed |
| Biallelic truncating variants in children with titinopathy represent a recognizable condition with distinctive muscular and cardiac characteristics: a report on five patients. | Front Cardiovasc Med | 2023 | 37576110 | PubTator, text mining | PubMed |
| Clinical Applications for Gasotransmitters in the Cardiovascular System: Are We There Yet? | Int J Mol Sci | 2023 | 37569855 | PubTator, text mining | PubMed |
| A highly sensitive nanochannel device for the detection of SUMO1 peptides. | Chem Sci | 2023 | 37564410 | PubTator, text mining | PubMed |
| T-type calcium channel modulation by hydrogen sulfide in neuropathic pain conditions. | Front Pharmacol | 2023 | 37529702 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/859/papers?page=7